Praxis Precision Medicines, Inc. (PRAX)
NASDAQ: PRAX · Real-Time Price · USD
310.71
+0.13 (0.04%)
At close: Mar 6, 2026, 4:00 PM EST
310.86
+0.15 (0.05%)
After-hours: Mar 6, 2026, 7:59 PM EST
PRAX Employees
Praxis Precision Medicines had 168 employees as of December 31, 2025. The number of employees increased by 52 or 44.83% compared to the previous year.
Employees
168
Change (1Y)
52
Growth (1Y)
44.83%
Revenue / Employee
n/a
Profits / Employee
-$1,805,167
Market Cap
8.65B
Employees Chart
Related Stocks
| Company Name | Employees |
|---|---|
| Bio-Techne | 3,100 |
| Axsome Therapeutics | 925 |
| Madrigal Pharmaceuticals | 915 |
| Arrowhead Pharmaceuticals | 711 |
| ImmunityBio | 691 |
| Cytokinetics | 673 |
| Vaxcyte | 507 |
| Halozyme Therapeutics | 423 |
PRAX News
- 2 days ago - Praxis Precision Medicines, Inc. (PRAX) Presents at TD Cowen 46th Annual Health Care Conference Transcript - Seeking Alpha
- 4 days ago - Praxis Precision Medicines, Inc. Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - GlobeNewsWire
- 16 days ago - Praxis Precision Medicine Analysts Raise Their Forecasts After Q4 Results - Benzinga
- 17 days ago - Praxis Precision Medicines, Inc. (PRAX) Q4 2025 Earnings Call Transcript - Seeking Alpha
- 17 days ago - Praxis Precision Medicines Provides Corporate Update and Reports Fourth Quarter and Full-Year 2025 Financial Results - GlobeNewsWire
- 27 days ago - Praxis Precision Medicines to Report Fourth Quarter and Full Year 2025 Financial Results on Thursday, February 19, 2026, and Participate in Upcoming Investor Conferences - GlobeNewsWire
- 4 weeks ago - SEQSTER Announces Expanded Partnership with Praxis Precision Medicines to Accelerate Clinical Trials in CNS Disorders - Business Wire
- 6 weeks ago - These 20 stocks are strong choices for momentum investors - Market Watch